Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-1350-2015

Drug recall · August 26, 2015

AMPICILLIN CAPSULES recall

Why: Labeling: Incorrect Or Missing Package Insert: Product is labeled with unapproved labeling.

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

AMPICILLIN CAPSULES, USP, 250 mg, 500 count bottles, Rx only, Manufactured for: DAVA Pharmaceuticals, Inc., Fort Lee, NJ, By: Suir Pharma Ireland Ltd., Clonmel, Ireland, NDC: 67253-180-50

Lots / codes

Lot #: 52217, Expiry: 04/18

Quantity
360 Bottles
Company
Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals, Huntsville, AL
Distribution
U.S. Including: OH
Initiated
August 13, 2015 · Voluntary: Firm initiated
Classified
August 20, 2015
Reported
August 26, 2015
Ended
August 21, 2015
How notified
Telephone

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Ampicillin

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.